MARATTO

article · Journal of Drug Delivery Science and Technology

Engineered exosomal delivery of semaglutide activates SIRT1–FOXO3a–miR-124 signaling and protects against cortical neuroinflammation

2026Delta University for Science and Technology

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Extracellular vesicles in disease
  • Barrier Structure and Function Studies
  • Sirtuins and Resveratrol in Medicine

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1016/j.jddst.2026.108078

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.